normal birth-weight and full-term infant
Conditions
Interventions
A group: The test formula is the infant formula containing heat-treated Bifidobacterim bifidum OLB6378
C group: The infant formula without Bifidobacterium bifidum OLB6378. It is indistinguishable from
Sponsors
Graduate School of Medicine, Chiba University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. normal birth-weight (2,500 g <= birth-weight < 4,000 g ) infant and his/her mother 2. full-term (37 weeks <= gestational age < 42 weeks) infant and his/her mother 3. Signed consent form to participate in the study was obtained from the infant's mother as the legal representative after full explanation of this study and its ethical considerations to persons in parental authority.
Exclusion criteria
Exclusion criteria: 1. infant with severe infection and his/her mother 2. infant with severe congenital abnormality and his/her mother 3. infant who is considered unsuitable subjects by the attending physician and his/her mother
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fecal IgA level of infants | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of Bifidobacterium bifidum in infant feces Frequency of eczema in the study infants | — |
Countries
Japan
Contacts
Public ContactHiroki Takayama
Soiken Inc. Clinical Study Support Division
Outcome results
None listed